SC: Recoveries U/S 27 of Evidence Act Alone Cannot Sustain Conviction; 1988 Murder Acquittal Restored  ||  SC: Successive Impleadment Applications are Barred by Res Judicata under Different CPC Provisions  ||  Supreme Court Halts Coercive Measures in CJP Protest Cases, Directs Release of Minors  ||  Supreme Court: National Commission for Scheduled Castes Lacks Power to Pass Binding Orders  ||  Bombay HC: Alleged Illegal Arrest Alone Cannot Trigger Contempt Action Against Police  ||  Bombay HC Quashes Order against Taiwan National, Says Online Study Didn't Breach Visa Rules  ||  P&H High Court Issues Directions on LADC Scheme After Reviewing Lawyers' Objections  ||  Allahabad HC: Suspension of Sentence Plea Need Not Take Priority if Appeal is Ready  ||  Allahabad High Court: Surcharge Recovery From Pradhan Must Follow Panchayat Raj Act Procedure  ||  Allahabad HC Directs IB Probe into 4 Lucknow Lawyers, Raises Concern over Lawyer-Police Nexus    

Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin” - (14 Dec 2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporation claiming monopoly rights on a new diabetes drug, teneligliptin, on grounds that it was "obvious, and lacking inventive step".

Tags : KOLKATA PATENT OFFICE   PATENT   DIABETES DRUG TENELIGLIPTIN  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved